Only clinical applications make Nightingale a valuable player – research helps justify it, but doesn’t in itself generate shareholder value. Both Terveystalo and the North Karelia wellbeing services county are clinical applications, but the real money is abroad.
Like in the solutions used by Kaiser Permanente, one of the largest health insurance groups in the United States. And now, researchers from Weill Cornell Medicine and Kaiser Permanente state in a new preprint based on 55k KP customers and biobank donors: the use of NMR metabolomics provides better disease incidence predictions than risk calculators.
Metabolomics improves disease prediction beyond clinical risk factors